Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.23.16 extracted from

  • Narendra Babu, S.N.; Rangappa, K.S.
    Design, synthesis and structure-activity study of shorter hexa peptide analogues as HIV-1 protease inhibitors (2008), Bioorg. Med. Chem., 16, 874-880.
    View publication on PubMed

Inhibitors

Inhibitors Comment Organism Structure
acetyl pepstatin 0.1 mg/ml, 98.5% inhibition Human immunodeficiency virus 1
Leu-Leu-Glu-Tyr-Val-Met-OH 0.1 mg/ml, 47.2% inhibition Human immunodeficiency virus 1
Leu-Leu-Glu-Tyr-Val-Phe-OH 0.1 mg/ml, 52.3% inhibition Human immunodeficiency virus 1
Leu-Leu-Glu-Tyr-Val-Trp-OH 0.1 mg/ml, 64.9% inhibition Human immunodeficiency virus 1
Leu-Leu-Glu-Tyr-Val-Tyr-OH 0.1 mg/ml, 58.6% inhibition Human immunodeficiency virus 1

Organism

Organism UniProt Comment Textmining
Human immunodeficiency virus 1
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
His-Lys-Ala-Arg-Val-Leu-(pNO2-Phe)-Glu-Ala-Nle-Ser-NH2 + H2O
-
Human immunodeficiency virus 1 ?
-
?